Stocks and Investing
Stocks and Investing
Thu, August 5, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Danielle Antalffy Maintained (TNDM) at Hold with Increased Target to $123 on, Aug 5th, 2021
Danielle Antalffy of SVB Leerink, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Hold with Increased Target from $102 to $123 on, Aug 5th, 2021.
Danielle has made no other calls on TNDM in the last 4 months.
There is 1 other peer that has a rating on TNDM. Out of the 1 peers that are also analyzing TNDM, 0 agree with Danielle's Rating of Hold.
This is the rating of the analyst that currently disagrees with Danielle
- Travis Steed of "Barclays" Initiated at Sell and Held Target at $90 on, Tuesday, May 25th, 2021
Contributing Sources